Carnitine supplement for heart failure with kidney issues
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether taking carnitine supplements by mouth can help people who have both heart failure and early-to-moderate kidney problems. It's an early-phase study to see if the supplement is safe and works for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure that also involves some kidney problems (cardiorenal syndrome).
- Your kidney disease is at stage 1, 2, 3a, 3b, or 4 (not stage 5 or on dialysis).
- You are 18 years old or older.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You have no history of seizures and no known allergy to carnitine or its tablet ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether finerenone can improve heart muscle thickening in patients with certain heart or kidney risk factors. It may help reduce heart strain and improve heart function.
This study tests whether adding L-arginine, an amino acid supplement, to your usual heart failure treatment can improve your heart's function. If you have heart failure with a reduced pumping ability, this could potentially help you feel better and improve your heart health.
This trial tests whether nutritional supplements can improve outcomes for people with heart failure. It aims to find an easy-to-follow, practical way to help manage the condition.
This trial tests whether a supervised exercise program can improve physical function in people who have both heart failure and kidney disease. If you join, you may get a structured workout plan supervised by professionals, which might help you feel stronger and do daily activities more easily.
This study tests whether adding selenium and CoQ10 (two natural supplements) to standard heart failure treatment helps people with chronic heart failure feel better and improve their health. Researchers are using a registry-based approach to track participants in the Netherlands.
This trial tests whether safely increasing the dose of standard heart failure medications can improve outcomes in people with a weak heart pump, while keeping a close eye on kidney function. It may be a good fit if you have heart failure with reduced ejection fraction and are not yet on the highest recommended doses of your medicines.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.